James C. Wittig

ASSOCIATE PROFESSOR Orthopaedics

Print Profile

Email

james.wittig@mountsinai.org

Specialty

Orthopaedic Surgery

Certifications

American Board of Orthopaedic Surgery

Clinical Focus

Education

MD, New York University School of Medicine
Internship, General Surgery
St. Lukes Roosevelt Hospital
Residency, Orthopaedic Surgery
Columbia University Medical Center
Fellowship, Orthopaedic Oncology
Washington Hospital Center

Biography

Dr. Wittig and his work diagnosing and treating osteosarcomas were recently profiled in The Daily News feature The Daily Check Up. View the PDF.

Awards

2009 -
Best Doctors
New York Magazine

Publications

Dean EM, Wittig JC, Vilalobos C, Garcia RA. A 16-year-old Boy with Multifocal, Painless Osseous Lesions. Clinical orthopaedics and related research 2012 April;.

Epelboyn Y, Desai K, Garcia R, Wittig JC. Painful Femur Lesion in a 43-year-old Woman. Clin Ortho Rel Res 2012 July; 470(7): 2067-72.

Rybak LD, Khaldi L, Wittig J, Steiner GC. Primary synovial chondrosarcoma of the hip joint in a 45-year-old male: case report and literature review. Skeletal Radiology 2011 Oct; 40(10): 1375-81.

Anderson MR, Jeng CL, Wittig JC, Rosenblatt MA. Anesthesia for Patients Undergoing Orthopedic Oncologic Surgeries. Journal of Clinical Anesthesia 2010 Nov; 22(7): 565-72.

Rybak LD, Gangi A, Buy X, La Rocca Vieira R, Wittig J. Thermal Ablation of Spinal Osteoid Osteomas Close to Neural Elements: Technical Considerations. AJR 2010 Oct; 195(4): 293-298.

Clear Cell Sarcoma of The Soft Tissue Localized in The Elbow. Case Report. Curr Ortho Prac. 2011 January/February; 22(1): 104-108.

Hochfelder J, Rybak LD, Garcia R, Wittig JC. Orthopaedic Case of the Month: A 30-year-old woman with a painful forearm mass. Clinical orthopaedics and related research 2010 Nov; 468(11): 3139-44.

Chatha DS, Rybak LD, Wittig JC, Desai P. Chest Wall Mass in a 50-year-old woman. Clinical orthopaedics and related research 2010 May; 468(5): 1462-6.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Wittig did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central